v3.25.4
INCOME TAXES
12 Months Ended
Dec. 31, 2025
INCOME TAXES  
INCOME TAXES

NOTE 10 – INCOME TAXES:

a.The Company has not recorded an income tax benefit for years ended December 31, 2025 and 2024, respectively. The Company has incurred net pre-tax losses in the United States only for all periods presented. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the carrying amounts of existing assets and liabilities in the financial statements and their respective tax bases using tax rates expected to be in effect during the years in which the basis differences reverse.

On July 4, 2025, the enactment of the One Big Beautiful Bill Act ("OBBBA") into law, marked a significant legislative development, resulting in substantial modifications to the U.S. tax code. The OBBBA influences multiple facets of taxation, including, but not limited to, maintaining the 21 percent corporate tax rate and makes permanent many of the beneficial expired and expiring tax provisions originally enacted in the Tax Cuts and Jobs Act of 2017, including the immediate expensing of domestic research and development expenditures, more favorable interest deductibility and 100 percent bonus depreciation with effective dates in 2025. Revisions to the international tax framework are effective in 2026. The income taxes reported for the year ended December 31, 2025 incorporate all relevant tax provisions of this new law.

b.

Tax Rates:

Income of the Company is taxed according to the federal tax laws in the US and the relevant state laws. The U.S tax rate in 2025 and 2024 is 26.9% comprising U.S statutory tax rates of 21% and state tax rate of 5.9%. For the years ended years ended December 31, 2025 and 2024, the Company’s effective tax rate is below the federal statutory income tax rate of 21% primarily due to state income taxes, net of federal benefit and the Company’s position to establish a full valuation allowance on its deferred tax assets.

c.

Corporate Taxation in the U.S.

The applicable corporate tax rate for the Company is 21%.

As of December 31, 2025, the Company has an accumulated tax loss carryforward of approximately $56.1 million (as of December 31, 2024, $43.0 million). Under U.S. tax laws, subject to certain limitations, carryforward tax losses originating in tax year have no expiration date, but they are limited to 80% of the company’s taxable income in any given tax year.

A reconciliation of the statutory U.S. federal rate to the Company’s effective tax rate is as follows:

  ​ ​ ​

For the year-ended

Percentage of pre-tax income

Statutory federal income tax rate

 

21%

 

21%

State taxes, net of federal tax benefit

 

6%

 

6%

R&D Tax Credit

 

(5)%

 

(5)%

Change in valuation allowance

(22)%

(22)%

Income taxes provision (benefit)

—%

—%

d.

Tax Assessments

The Company has not been taxed since its inception.

e.

Deferred Taxes

The tax effect of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets and liabilities are presented below:

  ​ ​ ​

As of

  ​ ​ ​

As of

December 31, 2025

December 31, 2024

(in thousands USD)

(in thousands USD)

Deferred tax asset:

 

  ​

 

  ​

Net operating loss carry forward

 

15,132

 

11,616

Share Compensation

 

5,165

 

3,542

Research and Development credits

 

52

 

52

Accruals and reserves

 

6,227

 

4,318

Total deferred tax assets

 

26,576

 

19,528

Valuation allowance

 

(26,576)

 

(19,528)

Deferred tax assets recognized

 

 

As the achievement of required future taxable income is not likely, the Company recorded a full valuation allowance. The following table presents a reconciliation of the beginning and ending valuation allowance:

  ​ ​ ​

As of

  ​ ​ ​

As of

December 31, 2025

December 31, 2024

(in thousands USD)

(in thousands USD)

Balance at beginning of the year

 

19,528

 

14,491

Additions to valuation allowance

 

7,048

 

5,037

Balance at end of the year

 

26,576

 

19,528